Hearing On Natco Plea To Make Generic Version Of Roche, Pfizer Cancer Drugs Extended To March

NEW DELHI - An Indian patent office hearing on the closely watched application by Hyderabad, India-based Natco Pharma for a compulsory license to sell generic copies of Roche and Pfizer drugs to poor countries will continue next month, a spokesman for the patent office said